Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years ...Middle East

PR Newswire - News
Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years
AUSTIN, Texas, Jan. 31, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic...

Hence then, the article about edwards resilia tissue aortic valve demonstrates favorable safety and efficacy at five years was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News